Characterizing the functional consequences of haploinsufficiency of NELF-A (WHSC2) and SLBP identifies novel cellular phenotypes in Wolf-Hirschhorn syndrome

Human Molecular Genetics

Volumn 21, Issue 10, 2012, Pages 2181-2193

  Kerzendorfer, Claudia ^a   Hannes, Femke ^b   Colnaghi, Rita ^a   Abramowicz, Iga ^a   Carpenter, Gillian ^a   Vermeesch, Joris Robert ^b   O'Driscoll, Mark ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CAMPTOTHECIN; DNA; ELONGATION FACTOR; HISTONE; MESSENGER RNA; MITOCHONDRIAL PROTEIN; NEGATIVE ELONGATION FACTOR; PROTEIN LETM1; SMALL INTERFERING RNA; STEM LOOP BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CHROMATIN; CHROMOSOME 4; CHROMOSOME DELETION; CHROMOSOME DELETION 4; CLINICAL FEATURE; CONTROLLED STUDY; DNA REPLICATION; GENE; GENE DELETION; GROWTH RETARDATION; HAPLOINSUFFICIENCY; HUMAN; HUMAN CELL; INTRAUTERINE GROWTH RETARDATION; MICROCEPHALY; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; WHSC2 GENE; WOLF HIRSCHHORN SYNDROME;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 4; DNA DAMAGE; HAPLOINSUFFICIENCY; HUMANS; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; NUCLEAR PROTEINS; PHENOTYPE; TRANSCRIPTIONAL ELONGATION FACTORS; WOLF-HIRSCHHORN SYNDROME;

EID: 84860469901     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds033     Document Type: Article

References (61)

1. Hirschhorn, K. and Cooper, H.L. (1961) Apparent deletion of short arms of one chromosome (4 or 5) in a child with defects of midline fusion. Mamm. Chromosome Newsl. IV, 14.
2. Hirschhorn, K., Cooper, H.L. and Firschein, I.L. (1965) Deletion of short arms of chromosome 4-5 in a child with defects of midline fusion. Humangenetik, 1, 479-482.
3. Wolf, U., Reinwein, H., Porsch, R., Schröter, R. and Baitsch, H. (1965) Defizienz an den kurzen Armen eines Chromosoms Nr. 4. Humangenetik, 1, 397.
4. Battaglia, A., Filippi, T. and Carey, J.C. (2008) Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision. Am. J. Med. Genet., 148C, 246-251.
5. Zollino, M., Murdolo, M., Marangi, G., Pecile, V., Galasso, C., Mazzanti, L. and Neri, G. (2008) On the nosology and pathogenesis of Wolf- Hirschhorn syndrome: genotype-phenotype correlation analysis of 80 patients and literature review. Am. J. Med. Genet., 148C, 257-269.
6. Maas, N.M.C., Van Buggenhout, G., Hannes, F., Thienpont, B., Sanlaville, D., Kok, K., Midro, A., Andrieux, J., Anderlid, B.-M., Schoumans, J. et al. (2008) Genotype-phenotype correlation in 21 patients with Wolf-Hirschhorn syndrome using high-resolution array comparative genome hybridisation (CGH). J. Med. Genet., 45, 71-80.
7. Van Buggenhout, G., Melotte, C., Dutta, B., Froyen, G., Van Hummelen, P., Marynen, P., Matthijs, G., de Ravel, T., Devriendt, K., Fryns, J.P. et al. (2004) Mild Wolf-Hirschhorn syndrome: micro-array CGH analysis of atypical 4p16.3 deletions enables refinement of the genotype-phenotype map. J. Med. Genet., 41, 691-698.
8. Zollino, M., Di Stefano, C., Zampino, G., Mastroiacovo, P., Wright, T.J., Sorge, G., Selicorni, A., Tenconi, R., Zappalà, A., Battaglia, A. et al. (2000) Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome. Am. J. Med. Genet., 94, 254-261.
9. South, S.T., Hannes, F., Fisch, G.S., Vermeesch, J.R. and Zollino, M. (2008) Pathogenic significance of deletions distal to the currently described Wolf-Hirschhorn syndrome critical regions on 4p16.3. Am. J. Med. Genet., 148C, 270-274.
10. Abrams, J.M. and Jiao, Y. (2009) Keeping it simple: what mouse models of Wolf-Hirschhorn syndrome can tell us about large chromosomal deletions. Dis. Model Mech., 2, 315-316.
11. Simon, R. and Bergemann, A.D. (2008) Mouse models of Wolf- Hirschhorn syndrome. Am. J. Med. Genet., 148C, 275-280.
12. Näf, D., Wilson, L.A., Bergstrom, R.A., Smith, R.S., Goodwin, N.C., Verkerk, A., van Ommen, G.J., Ackerman, S.L., Frankel, W.N. and Schimenti, J.C. (2001) Mouse models for the Wolf-Hirschhorn deletion syndrome. Hum. Mol. Genet., 10, 91-98.
13. Endele, S., Fuhry, M., Pak, S.-J., Zabel, B.U. and Winterpacht, A. (1999) LETM1, a novel gene encoding a putative EF-hand Ca2+-binding protein, flanks the Wolf-Hirschhorn syndrome (WHS) critical region and is deleted in most WHS patients. Genomics, 60, 218-225.
14. Nimura, K., Ura, K., Shiratori, H., Ikawa, M., Okabe, M., Schwartz, R.J. and Kaneda, Y. (2009) A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature, 460, 287-291.
15. South, S.T., Bleyl, S.B. and Carey, J.C. (2007) Two unique patients with novel microdeletions in 4p16.3 that exclude the WHS critical regions: implications for critical region designation. Am. J. Med. Genet., 143A, 2137-2142.
16. Engbers, H., van der Smagt, J.J., Van't Slot, R., Vermeesch, J.R., Hochstenbach, R. and Poot, M. (2008) Wolf-Hirschhorn syndrome facial dysmorphic features in a patient with a terminal 4p16.3 deletion telomeric to the WHSCR and WHSCR 2 regions. Eur. J. Hum. Genet., 17, 129-132.
17. White, D.M., Pillers, D.A., Reiss, J.A., Brown, M.G. and Magenis, R.E. (1995) Interstitial deletions of the short arm of chromosome 4 in patients with a similar combination of multiple minor anomalies and mental retardation. Am. J. Med. Genet., 57, 588-597.
18. Wright, T.J., Ricke, D.O., Denison, K., Abmayr, S., Cotter, P.D., Hirschhorn, K., Keinänen, M., McDonald-McGinn, D., Somer, M., Spinner, N. et al. (1997) A transcript map of the newly defined 165 kb Wolf-Hirschhorn syndrome critical region. Hum. Mol. Genet., 6, 317-324.
19. Zollino, M., Lecce, R., Fischetto, R., Murdolo, M., Faravelli, F., Selicorni, A., Buttè, C., Memo, L., Capovilla, G. and Neri, G. (2003) Mapping the Wolf-Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2. Am. J. Hum. Genet., 72, 590-597.
20. Rodríguez, L., Zollino, M., Climent, S., Mansilla, E., López-Grondona, F., Martínez-Fernández, M.L., Murdolo, M. and Martínez-Frías, M.L. (2005) The new Wolf-Hirschhorn syndrome critical region (WHSCR-2): a description of a second case. Am. J. Med. Genet., 136A, 175-178.
21. Rauch, A., Schellmoser, S., Kraus, C., Dörr, H.G., Trautmann, U., Altherr, M.R., Pfeiffer, R.A. and Reis, A. (2001) First known microdeletion within the Wolf-Hirschhorn syndrome critical region refines genotype- phenotype correlation. Am. J. Med. Genet., 99, 338-342.
22. Marango, J., Shimoyama, M., Nishio, H., Meyer, J.A., Min, D.-J., Sirulnik, A., Martinez-Martinez, Y., Chesi, M., Bergsagel, P.L., Zhou, M.-M. et al. (2008) The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor. Blood, 111, 3145-3154.
23. Kim, J.-Y., Kee, H.J., Choe, N.-W., Kim, S.-M., Eom, G.-H., Baek, H.J., Kook, H., Kook, H. and Seo, S.-B. (2008) Multiple myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity. Mol. Cell. Biol., 28, 2023-2034.
24. Li, Y., Trojer, P., Xu, C.-F., Cheung, P., Kuo, A., Drury, W.J., Qiao, Q., Neubert, T.A., Xu, R.-M., Gozani, O. et al. (2009) The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate. J. Biol. Chem., 284, 34283-34295.
25. Brito, J.L.R., Walker, B., Jenner, M., Dickens, N.J., Brown, N.J.M., Ross, F.M., Avramidou, A., Irving, J.A.E., Gonzalez, D., Davies, F.E. et al. (2009) MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells. Haematologica, 94, 78-86.
26. Keats, J.J., Maxwell, C.A., Taylor, B.J., Hendzel, M.J., Chesi, M., Bergsagel, P.L., Larratt, L.M., Mant, M.J., Reiman, T., Belch, A.R. et al. (2005) Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients. Blood, 105, 4060-4069.
27. Narita, T., Yung, T.M.C., Yamamoto, J., Tsuboi, Y., Tanabe, H., Tanaka, K., Yamaguchi, Y. and Handa, H. (2007) NELF interacts with CBC and participates in 3' end processing of replication-dependent histone mRNAs. Mol. Cell, 26, 349-365.
28. Gilchrist, D.A., Nechaev, S., Lee, C., Ghosh, S.K.B., Collins, J.B., Li, L., Gilmour, D.S. and Adelman, K. (2008) NELF-mediated stalling of Pol II can enhance gene expression by blocking promoter-proximal nucleosome assembly. Genes Dev., 22, 1921-1933.
29. Yung, T.M.C., Narita, T., Komori, T., Yamaguchi, Y. and Handa, H. (2009) Cellular dynamics of the negative transcription elongation factor NELF. Exp. Cell Res., 315, 1693-1705.
30. Dimmer, K.S., Navoni, F., Casarin, A., Trevisson, E., Endele, S., Winterpacht, A., Salviati, L. and Scorrano, L. (2008) LETM1, deleted in Wolf-Hirschhorn syndrome is required for normal mitochondrial morphology and cellular viability. Hum. Mol. Genet., 17, 201-214.
31. McQuibban, A.G., Joza, N., Megighian, A., Scorzeto, M., Zanini, D., Reipert, S., Richter, C., Schweyen, R.J. and Nowikovsky, K. (2010) A Drosophila mutant of LETM1, a candidate gene for seizures in Wolf- Hirschhorn syndrome. Hum. Mol. Genet., 19, 987-1000.
32. + homeostasis with a potential role in the Wolf-Hirschhorn syndrome. J. Biol. Chem., 279, 30307-30315.
33. Zhao, X., McKillop-Smith, S. and Muller, B. (2004) The human histone gene expression regulator HBP/SLBP is required for histone and DNA synthesis, cell cycle progression and cell proliferation in mitotic cells. J. Cell Sci., 117, 6043-6051.
34. Bonner, W.M., Wu, R.S., Panusz, H.T. and Muneses, C. (1998) Kinetics of accumulation and depletion of soluble newly synthesized histone in the reciprocal regulation of histone and DNA synthesis. Biochemistry, 23, 6542-6550.
35. Groth, A., Rocha, W., Verreault, A. and Almouzni, G. (2007) Chromatin challenges during DNA replication and repair. Cell, 128, 721-733.
36. Marzluff, W.F., Wagner, E.J. and Duronio, R.J. (2008) Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat. Rev. Genet., 9, 843-854.
37. Jaeger, S., Barends, S., Giegé, R., Eriani, G. and Martin, F. (2005) Expression of metazoan replication-dependent histone genes. Biochimie, 87, 827-834.
38. Allard, P., Yang, Q., Marzluff, W.F. and Clarke, H.J. (2005) The stem- loop binding protein regulates translation of histone mRNA during mammalian oogenesis. Dev. Biol., 286, 195-206.
39. Ingledue, T.C., Dominski, Z., Sánchez, R., Erkmann, J.A. and Marzluff, W.F. (2000) Dual role for the RNA-binding domain of Xenopus laevis SLBP1 in histone pre-mRNA processing. RNA, 6, 1635-1648.
40. Zheng, L., Dominski, Z., Yang, X.-C., Elms, P., Raska, C.S., Borchers, C.H. and Marzluff, W.F. (2003) Phosphorylation of stem-loop binding protein (SLBP) on two threonines triggers degradation of SLBP, the sole cell cycle-regulated factor required for regulation of histone mRNA processing, at the end of S phase. Mol. Cell. Biol., 23, 1590-1601.
41. Kaygun, H. and Marzluff, W.F. (2005) Translation termination is involved in histone mRNA degradation when DNA replication is inhibited. Mol. Cell. Biol., 25, 6879-6888.
42. Margueron, R. and Reinberg, D. (2010) Chromatin structure and the inheritance of epigenetic information. Nat. Rev. Genet., 11, 285-296.
43. Jasencakova, Z. and Groth, A. (2010) Replication stress, a source of epigenetic aberrations in cancer? BioEssays, 32, 847-855.
44. Jasencakova, Z. and Groth, A. (2010) Restoring chromatin after replication: how new and old histone marks come together. Semin. Cell Dev. Biol., 21, 231-237.
45. Sun, J. and Li, R. (2010) Human negative elongation factor activates transcription and regulates alternative transcription initiation. J. Biol. Chem., 285, 6443-6452.
46. Hannes, F., Houdt, J.V., Quarrell, O.W., Poot, M., Hochstenbach, R., Fryns, J.-P. and Vermeesch, J.R. (2010) Telomere healing following DNA polymerase arrest-induced breakages is likely the main mechanism generating chromosome 4p terminal deletions. Hum. Mut., 31, 1343-1351.
47. Sullivan, K.D., Mullen, T.E., Marzluff, W.F. and Wagner, E.J. (2009) Knockdown of SLBP results in nuclear retention of histone mRNA. RNA, 15, 459-472.
48. Wagner, E.J., Berkow, A. and Marzluff, W.F. (2005) Expression of an RNAi-resistant SLBP restores proper S-phase progression. Biochem. Soc. Trans., 33, 471-473.
49. Groth, A., Ray-Gallet, D., Quivy, J.-P., Lukas, J., Bartek, J. and Almouzni, G. (2005) Human Asf1 regulates the flow of S phase histones during replicational stress. Mol. Cell, 17, 301-311.
50. Ye, X., Franco, A.A., Santos, H., Nelson, D.M., Kaufman, P.D. and Adams, P.D. (2003) Defective S phase chromatin assembly causes DNA damage, activation of the S phase checkpoint, and S phase arrest. Mol. Cell, 11, 341-351.
51. Jasencakova, Z., Scharf, A.N.D., Ask, K., Corpet, A., Imhof, A., Almouzni, G. and Groth, A. (2010) Replication stress interferes with histone recycling and predeposition marking of new histones. Mol. Cell, 37, 736-743.
52. Campos, E.I., Fillingham, J., Li, G., Zheng, H., Voigt, P., Kuo, W.-H.W., Seepany, H., Gao, Z., Day, L.A., Greenblatt, J.F. et al. (2010) The program for processing newly synthesized histones H3.1 and H4. Nat. Struct. Mol. Biol., 17, 1343-1351.
53. Groth, A., Corpet, A., Cook, A.J.L., Roche, D., Bartek, J., Lukas, J. and Almouzni, G. (2007) Regulation of replication fork progression through histone supply and demand. Science, 318, 1928-1931.
54. Azzalin, C.M. and Lingner, J. (2006) The human RNA surveillance factor UPF1 is required for S phase progression and genome stability. Curr. Biol., 16, 433-439.
55. Kaygun, H. and Marzluff, W.F. (2005) Regulated degradation of replication-dependent histone mRNAs requires both ATR and Upf1. Nat. Struct. Mol. Biol., 12, 794-800.
56. Pourquier, P. and Pommier, Y. (2001) Topoisomerase I-mediated DNA damage. Adv. Can. Res., 80, 189-216.
57. Prado, F. and Aguilera, A. (2005) Partial depletion of histone H4 increases homologous recombination-mediated genetic instability. Mol. Cell. Biol., 25, 1526-1536.
58. Meeks-Wagner, D. and Hartwell, L.H. (1986) Normal stoichiometry of histone dimer sets is necessary for high fidelity of mitotic chromosome transmission. Cell, 44, 43-52.
59. O'Driscoll, M. and Jeggo, P.A. (2008) The role of the DNA damage response pathways in brain development and microcephaly: insight from human disorders. DNA Repair, 7, 1039-1050.
60. O'Driscoll, M. (2009) Mouse models for ATR deficiency. DNA Repair, 8, 1333-1337.
61. Bicknell, L.S., Walker, S., Klingseisen, A., Stiff, T., Leitch, A., Kerzendorfer, C., Martin, C.-A., Yeyati, P., Al Sanna, N., Bober, M. et al. (2011) Mutations in ORC1, encoding the largest subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome. Nat. Genet., 43, 350-355.